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Abstract 
GRB2/Sem-5 is a 25-kDa adaptor protein which contains a central Src homology type 2 (SH2) domain flanked by two Src homology type 3 (SH3) 
domains. GRBUSem-5 was first identified due to the essential role of the sem-5 gene product in the vulva1 induction pathway in Caenorhabditis elegant. 
The SH2 domain of GRBUSem-5 binds to a number of tyrosine phosphorylated proteins, most notably the epidermal growth factor receptor, the 
insulin receptor substrate IRS-l and another putative adaptor protein, She. The SH3 domains bind to SOS, a guanine nucleotide exchange factor 
for Ras proteins. GRB2/Sem-5 brings together SOS and tyrosine phosphoproteins into a complex and thereby may regulate the nucleotide xchange 
rate of Ras and hence its activation state. 
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1. Introduction 
The low molecular weight GTP binding proteins of the 
Ras family have long been known to play a key role in 
the regulation of cellular growth and differentiation. 
They are biologically active when bound to GTP and 
inactive when bound to GDP. Their activation state in 
the cell is regulated by the opposing effects of two sets 
of proteins, the GTPase activating proteins (GAPS) 
which stimulate the intrinsic rate of hydrolysis of GTP 
on Ras, and the guanine nucleotide exchange factors that 
accelerate the replacement of bound GDP with fresh 
GTP from the cytosol (reviewed in [1,2]). Ras is stimu- 
lated in whole cells on exposure to a number of growth 
stimulatory factors. In certain cases these have been 
shown to activate Ras by suppressing GAP activity [3], 
but more commonly the activity of guanine nucleotide 
exchange factors is increased [4-61. Investigation of the 
mechanisms by which growth factors control the activity 
of guanine nucleotide exchange factors towards Ras has 
lead to the identification of GRB2/Sem-5 as a key com- 
ponent of this pathway. 
*Corresponding author. Fax: (44) (71) 269 3092. 
2. The role of Semd in C. &guns vulva1 development 
In the nematode worm the genetics of the development 
of the vulva has been mapped out in some detail. Vulva1 
precursor cells carry the Let-23 receptor tyrosine kinase; 
when this interacts with its ligand, Lin-3, expressed on 
the surface of the anchor cell, a signal inducing differen- 
tiation to a vulva1 cell fate is transmitted into the vulva1 
precursor cell [7]. A gene, let-60, lying downstream of 
let-23 on this pathway encodes a worm homologue of 
Ras [8,9]. More recently, Sem-5 was identified as another 
component of this pathway, functioning upstream of Ras 
but downstream of Let-23 [lo] (see Fig. 1). 
From its sequence, Sem-5 appeared to be an ‘adaptor’ 
protein, one containing only domains capable of binding 
other proteins but not having any intrinsic enzymatic 
activity of its own. Sem-5 is made up of a central Src 
homology type 2 (SH2) domain, flanked by two Src ho- 
mology type 3 (SH3) domains. This structure is reminis- 
cent of Crk, a proto-oncogene product whose function 
is poorly understood [l 11. SH2 domains bind to protein 
tyrosine phosphorylation sites [12], while SH3 domains 
bind to proline-rich motifs in proteins [13]. Mutations in 
Sem-5 that inhibited vulva1 development occurred in res- 
idues that were highly conserved in the SH2 and SH3 
consensus sequences. Although the full significance of 
these observations was not immediately clear, it was ob- 
vious that Sem-5 was likely to function to couple a recep- 
tor tyrosine kinase to an activator of Ras, possibly a 
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Fig. 1. Comparison of Ras regulatory pathways in different multicellar 
organisms. See text for details. 
guanine nucleotide exchange factor. Since the data from 
this system was entirely genetic, it was impossible to 
know how direct these interactions might be. 
3. GRB2 is a growth factor receptor binding protein 
GRB2, the mammalian homologue of Sem-5, was 
cloned independently due to its ability to bind to tyrosine 
phosphorylated proteins through its SH2 domain. GRB2 
clones were identified by screening a bacterial cDNA 
expression library with the tyrosine phosphorylated car- 
boxy terminal region of the epidermal growth factor re- 
ceptor [14]. The name, standing for growth factor recep- 
tor-bound protein 2 reflects the cloning protocol. The rat 
homologue of GRB2 was cloned independently using a 
consensus probe for SH2 sequences and was initially 
named ASH, for abundant Src homology protein [15]. 
Mouse GRB2 was subsequently cloned using a PCR 
method with probes based on the SH2 and SH3 domains 
of Vav [16]. 
The SH2 domain of GRB2 binds to the tyrosine auto- 
phosphorylation sites of activated EGF receptor [14], 
suggesting that the interaction of Sem-5 with Let-23 is 
direct. GRB2 has the same structure as Sem-5 with two 
SH3 domains and one SH2 domain in the order SH3- 
SH2-SH3. The N-terminal SH3 domain stretches from 
amino acids 5 to 55, the SH2 domain stretches from 
,amino acids 60 to 158 and the C-terminal SH3 domain 
stretches from amino acids 164 to 214. The human and 
rat protein sequences are identical, with the mouse se- 
quence differing at one position (M for V at 154). Human 
GRB2 shares 58% identity with C. elegans Sem-5. The 
sequences of GRB2 and Sem-5 are compared in Fig. 2. 
4. The role of GRB2/Sem-5 in Drosophila eye development 
During the development of the photoreceptor R7 cell 
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in the fruit fly retina, Sevenless, a receptor tyrosine ki- 
nase on surface of the R7 precursor cell interacts with its 
ligand, Boss, on the apposed R? cell. This interaction 
generates a signal leading to development of the precur- 
sor cell to an R7 phenotype. The Rasl protein functions 
downstream of Sevenless. Between Sevenless and Ras 
another component was identified which was named SOS, 
or Son of sevenless [17-191. The SOS protein has homol- 
ogy to CDC25, a guanine nucleotide exchange factor for 
Ras from Saccharomyces cerevisiae, and is therefore 
likely to act as an exchange factor for Ras in the Droso- 
phila eye. 
The Drosophila homologue of GRB2/Sem-5, named 
Drk for ‘downstream of receptor kinase’, was subse- 
quently cloned using exactly the same procedure as for 
human GRB2 [20]. It was then shown that the drk gene 
product functions downstream of the Sevenless receptor 
tyrosine kinase and upstream of SOS in R7 development 
(see Fig. 1). Simultaneously, an Enhancer of sevenless 
gene, whose product acted in the same way, was cloned 
by using P element insertion [21] and shown to encode 
the same GRB2/Sem-5 homologue. Human GRB2 
shares 63% identity with Drosophila Drk. Sem-5 and Drk 
are 61% identical. This genetic evidence indicated that 
GRB2/Sem-5 couples a receptor tyrosine kinase to a gua- 
nine nucleotide exchange factor for Ras, although the 
directness of the interactions could not be predicted. 
5. GRB2/Sem-5 links receptors and SOS 
At the same time as work on the genetics of Drosophila 
Drk was suggesting that GRB2/Sem-5 was involved in 
linking receptor tyrosine kinases to exchange factors for 
Ras, a number of groups working on mammalian sys- 
tems reported that GRB2/Sem-5 forms direct complexes 
with both activated growth factor receptors and the SOS 
exchange factors for Ras. The two murine homologues 
of SOS were cloned by homology to the Drosophila 
cDNA [22]. Subsequently, the human version of Sosl 
I SR3 
GRB2 1 MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPK 50 
IlI:l..II.I...IlIIIIIl:./III/.: I.:Il/III:I.:/llI. 
Sem-5 1 MEAVAEHDFQAGSPDELSFKRGNTLKVLNKDEDPHWYKAELDGNEGFIPS 50 
- ! Sri2 
GRB2 51 NYIEMKPHPWFFGKIPRAKAEEM~SKQR.HDGAFLIRESESAPGDFSLSV 99 
III I.. l::lll.l..Il :t.1. :It II:/::lI./I:II:/l 
Sem-5 51 NYIRMTE~NWYLGKITRNDAE~LLKKPTVRDGHFLVRQCESSPGEFSISV 100 
skl2 
GRBZ 100 KFGNDVQHFKVLRDGAGKYFLWWKFNSLNELVDYHRSTSVSRNQQIFLR 149 
:I.:.lllllllII..I/I:ll.l/l1llllll.lll..ll/l.: I:,. 
Sem-5 101 RFQDSVQHFKVLRDQNGKYYLWAVKFNSLNELVAYHRTASVSRTHTILLS 150 
SB3- 
GRB2 150 DIEQVPQQPTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACH 199 
I:: :..:lIlIIIl:III./Il:l:lll.I :::..II/I/.I. : 
Sem-5 151 DMN...VETKFVQALFDFNPQESGELAFKRGD"~TL~NKDDPN~WEGQLN 197 
GRB2 200 GQTGMFPRNYVTPVNRNV 217 
l:ll.IIl.I I.1 
Sem-5 198 NRRGIFPSNYVCPYNSNKSNSNVAPGFNFGN 228 
Fig. 2. Comparison of the protein sequences of GRB2 and Sem-5. The 
location of the SH3 and SH2 domains are shown above the sequence. 
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Fig. 3. A model for the regulation of Ras by EGF acting through GRB2 
and SOS. See text for details. 
was also cloned [23]. GRB2 can be found in a complex 
with SOS in mammalian cells [23-271. In most cell types 
the association of SOS and GRB2 was found to be consti- 
tutive, although in Rat-l fibroblasts it was shown to be 
inducible by EGF [24]. The interaction occurred between 
the SH3 domains of GRB2 and proline-rich sequences 
in the carboxy-terminal region of SOS [25,26]. 
At the same time, GRB2 interacted with the activated, 
autophosphorylated EGF receptor but not the inactive 
receptor. EGF treatment of cells therefore leads to for- 
mation of complexes of receptor, GRB2 and SOS at the 
plasma membrane (see Fig. 3). Given the background of 
genetic information from C. elegans and Drosophila, it 
appears very likely that formation of such a complex 
leads to activation of the rate of nucleotide exchange on 
Ras: this has not yet been definitively proved and could 
occur through a number of mechanisms. Two likely pos- 
sibilities are by allosteric regulation of SOS on binding 
GRB2/EGF receptor or by translocation of SOS to the 
plasma membrane where both EGF receptor and Ras 
are located. By subcellular fractionation, both SOS and 
GRB2 are located in the cytosol of unstimulated cells 
but, in some cases, translocation to the particulate frac- 
tion has been observed upon EGF stimulation [24]. As 
yet there is no evidence for allosteric regulation of the 
activity of SOS by complex formation. 
In addition to the activated EGF receptor, GRB2 has 
been shown to be bound in cell lysates to the tyrosine 
phosphorylated insulin receptor substrate, IRS-l [28- 
3 11, the adaptor protein SHC [32], the chimeric oncogene 
product BCR-ABL [33] and the middle T antigen of 
polyoma virus. All of these proteins have in some way 
been linked to activation of Ras and all are, at least 
partly, localised to the particulate fraction. Binding of 
GRB2 to a number of other tyrosine phosphorylated 
proteins and peptides has been demonstrated in vitro, 
although the significance of these interactions is not al- 
ways clear. It is very likely that binding can be forced to 
occur in vitro using high concentrations of bacterially 
expressed GRB2 fusion proteins and overexpressed tyro- 
sine phosphorylated proteins or synthetic tyrosine 
phosphopeptides which does not reflect physiologically 
significant interaction in vivo. 
6. She may provide another route to GRB2 activation 
The adaptor protein She consists of one SH2 domain 
and a region of homology to collagen, but no SH3 do- 
mains [34]. She becomes phosphorylated on tyrosine in 
response to treatment of cells with a wide variety of 
growth stimuli, and also binds directly to the auto- 
phosphorylated EGF receptor through its SH2 domain. 
The SH2 domain of GRB2 will bind to tyrosine 
phosphorylated She [32]. She will act as an oncogene to 
cause transformation of fibroblasts when overexpressed, 
and will also induce neurite outgrowth in PC12 cells in 
a manner sensitive to inhibition by expression of domi- 
nant negative Ras mutants. She therefore acts in a man- 
ner consistent with it being an upstream activator of Ras. 
While the exact mechanism underlying these phenomena 
is unknown, it is possible that the interaction of GRB2I 
SOS with phosphorylated She leads to activation of nucle- 
otide exchange on Ras in a similar way to the interaction 
with phosphorylated EGF receptor or IRS-l. In many 
signalling pathways leading to Ras activation, for exam- 
ple that regulated by NGF, GRB2 does not bind to any 
receptor, but inducible Shc/GRB2 interaction does occur 
[16]. She binding to GRB2 could act as an alternative 
route to activate SOS, again either through translocation 
to the membrane or through allosteric regulation (see 
Fig. 4). A major portion of She is particulate (J.D., un- 
published observations); in addition it can bind to cer- 
tain activated receptors such as the EGF receptor. It is 
not clear whether binding to the receptor, as opposed to 
phosphorylation by it, is essential for She function. 
7. Characterisation of GRB2 in intact cells 
The ability of GRB2 to form complexes with SOS and 
receptors suggests that it may be capable of promoting 
cellular growth when overexpressed. This proves to be 
the case only under certain circumstances, either when 
excess Ras is present [14] or when EGF receptors are 
overexpressed [35]. In the absence of overexpression of 
other components of the pathway, excess GRB2 can ac- 
tually inhibit signalling to Ras (J.D., unpublished obser- 
Grb2 Pl.Cl rich 
Fig. 4. A possible model for the involvement of She in GRB2 mediated 
signalling from NGF. See text for details. 
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vations); presumably this occurs through the blocking of 
SoslGRB2 binding to tyrosine phosphoproteins by free 
GRB2. However, blocking GRB2 function by microin- 
jection of antibodies against it into mammalian cells 
blocked the induction of S phase entry and the induction 
of membrane ruffling in response to PDGF and EGF 
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GRB2 and its invertebrate homologues, Sem-5 in C. ele- 
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closer to understanding the mechanisms by which the 
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signalling pathways upstream of Ras appear to have 
been identified. The SH2 domain of GRB2 binds to tyro- 
sine phosphorylated proteins, including receptor tyro- 
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bind to the Ras guanine nucleotide exchange factor, SOS. 
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tion. 
1211 
P21 
~231 
Simon, M.A., Dodson, G.S. and Rubin, G.M. (1993) Cell 73, 
1699177. 
Bowtell, D., Fu, P., Simon, M. and Senior, P. (1992) Proc. Natl. 
Acad. Sci. USA 89, 6511-6515. 
Chardin, P., Camonis, J.H., Gale, N.W., Van Aelst, L., Schles- 
singer, J., Wigler, M. and Bar-Sagi, D. (1993) Science 260, 1338- 
1343. 
1241 
1251 
WI 
1271 
Buday, L. and Downward, J. (1993) Cell 73, 61 I-620. 
Egan, S.E., Giddings, B.W., Brooks, M.W., Buday, L., Sizeland. 
A.M. and Weinberg, R.A. (1993) Nature 363, 45-51. 
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. and 
Bowtell, D. (1993) Nature 363, 83-85. 
Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., 
Bar-Sagi, D., Margolis, B. and Schlessinger, J. (1993) Nature 363, 
85-88. 
[28] Skolnik, E.Y., Batzer, A., Li, N., Lee, C.-H., Lowenstein, E., 
Mohammadi, M., Margolis, B. and Schlessinger, J. (1993) Science 
260, 1953-1955. 
References 
[29] Skolnik, E.Y., Lee, C.-H., Batzer, A., Vicentini, L.M., Zhou, M., 
Daly, R., Myers, M.J., Backer, J.M., Ullrich, A., White, M.F. and 
Schlessinger, J. (1993) EMBO J. 12, 1929-1936. 
[30] Tobe, K., Matuoka, K., Tamemoto, H., Ueki, K., Kaburagi, Y., 
Asai, S., Noguchi, T., Matsuda, M., Tanaka, S., Hattori, S., 
Fukui, Y., Akanuma, Y., Yazaki, Y., Takenawa, T. and Ka- 
dowaki, T. (1993) J. Biol. Chem. 268, 11167-11171. 
[31] Baltensperger, K., Kozma, L.M., Cherniack, A.D., Klarlund, 
J.K., Chawla, A., Banerjee, U. and Czech, M.P. (1993) Science 
260, 1950-1952. 
[l] Downward, J. (1992) BioEssays 14, 177-184. [32] Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., 
[2] Lowy, D.R. and Willumsen, B.M. (1993) Annu. Rev. Biochem. 62, Daly, R., Li, W., Batzer, A., Thomas, S., Brugge, J., Pelicci, P.G., 
851-891. Schlessinger, J. and Pawson, T. (1992) Nature 360, 689-692. 
J. DownwardlFEBS Letters 338 (1994) 113-117 117 
[33] Pendergast, A.M., Quilliam, L.A., Cripe, L.D., Bassing, C.H., 
Dai, Z., Li, N., Batzer, A., Rabun, K.M., Der, C.J., Schlessinger, 
J. and Gishiiky, M.L. (1993) Cell 75, 175-185. 
[34] Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, 
F., Fomi, G., Nicoletti, I., Grignani, F., Pawson, T. and Pelicci, 
P.G. (1992) Cell 70, 93-104. 
[35] Gale, N.W., Kaplan, S., Lowenstein, E.J., Schlessinger, J. and 
Bar-Sagi, D. (1993) Nature 363, 88-92. 
[36] Matuoka, K., Shibasaki, F., Shibata, M. and Takenawa, T. (1993) 
EMBO J. 12, 3467-3473. 
[37] Bar-Sagi, D., Rotin, D., Batzer, A., Mandiyan, V. and Schlessin- 
ger, J. (1993) Cell 74, 83-91. 
[38] Gout, I., Dhand, R., Hiles, I.D., Fry, M.J., Panayotou, G., Das, 
P., Truong, O., Totty, N.F., Hsuan, J., Booker, G.W., Campbell, 
I.D. and Waterfield, M.D. (1993) Cell 75, 25-36. 
